Jialiang Lin

2.3k total citations
92 papers, 1.7k citations indexed

About

Jialiang Lin is a scholar working on Pathology and Forensic Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Jialiang Lin has authored 92 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pathology and Forensic Medicine, 22 papers in Surgery and 21 papers in Molecular Biology. Recurrent topics in Jialiang Lin's work include Spine and Intervertebral Disc Pathology (28 papers), Musculoskeletal pain and rehabilitation (11 papers) and Cervical and Thoracic Myelopathy (10 papers). Jialiang Lin is often cited by papers focused on Spine and Intervertebral Disc Pathology (28 papers), Musculoskeletal pain and rehabilitation (11 papers) and Cervical and Thoracic Myelopathy (10 papers). Jialiang Lin collaborates with scholars based in China, United Kingdom and Saudi Arabia. Jialiang Lin's co-authors include Xiangyang Wang, Xuan-Qi Zheng, Weishi Li, Zengjie Zhang, Xiaolei Zhang, Shuai Jiang, Yongzhao Zhao, Weiyang Gao, Tianzhen Xu and Aimin Wu and has published in prestigious journals such as Applied Catalysis B: Environmental, Journal of Cleaner Production and Chemical Engineering Journal.

In The Last Decade

Jialiang Lin

83 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jialiang Lin China 25 658 459 353 336 206 92 1.7k
Zengjie Zhang China 28 822 1.2× 694 1.5× 459 1.3× 368 1.1× 270 1.3× 59 2.2k
Haiming Jin China 27 515 0.8× 569 1.2× 280 0.8× 347 1.0× 228 1.1× 68 1.7k
Zhen Sun China 28 630 1.0× 562 1.2× 443 1.3× 454 1.4× 322 1.6× 70 2.1k
Xiaopeng Zhou China 29 786 1.2× 685 1.5× 500 1.4× 443 1.3× 191 0.9× 66 2.0k
Zhenxuan Shao China 21 388 0.6× 341 0.7× 218 0.6× 285 0.8× 169 0.8× 46 1.3k
Quan Wang China 28 284 0.4× 912 2.0× 261 0.7× 174 0.5× 338 1.6× 63 2.7k
Min Dai China 22 256 0.4× 528 1.2× 197 0.6× 460 1.4× 139 0.7× 114 1.5k
Yao Li China 24 490 0.7× 855 1.9× 97 0.3× 261 0.8× 187 0.9× 86 1.8k
Qian Xiang China 16 642 1.0× 526 1.1× 361 1.0× 155 0.5× 178 0.9× 27 1.2k
Liming Cheng China 21 679 1.0× 418 0.9× 175 0.5× 509 1.5× 49 0.2× 85 1.7k

Countries citing papers authored by Jialiang Lin

Since Specialization
Citations

This map shows the geographic impact of Jialiang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jialiang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jialiang Lin more than expected).

Fields of papers citing papers by Jialiang Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jialiang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jialiang Lin. The network helps show where Jialiang Lin may publish in the future.

Co-authorship network of co-authors of Jialiang Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jialiang Lin. A scholar is included among the top collaborators of Jialiang Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jialiang Lin. Jialiang Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Huang, Yuxin, Liwen Tang, Rui‐Xiang Hu, et al.. (2025). Cu-doped MIL-101(Fe) with unsaturated metal sites activate peroxymonosulfate for efficient degradation of ciprofloxacin: Optimization, mechanism, and toxicity assessment. Inorganic Chemistry Communications. 175. 114181–114181. 2 indexed citations
4.
Chen, Qian, Jialiang Lin, Xinyu Wang, et al.. (2025). Preparation of Biochar Derived From Lychee Shell and Its Application in Simultaneous Detection of Catechol and Hydroquinone. Journal of Applied Polymer Science. 142(20). 1 indexed citations
6.
Lin, Jialiang, Zhijun Wu, Tommaso Cai, et al.. (2025). Balancing the 24-hour lifestyle: A population-based study on reducing mental health problems, self-injurious thoughts and behaviors among adolescents. Journal of Affective Disorders. 387. 119451–119451. 1 indexed citations
7.
Chen, Yiqi, Changyuan Yu, Morgan Jones, et al.. (2025). The global burden of motor neuron disease: a systematic and additional analysis of global burden disease study 2021. Orphanet Journal of Rare Diseases. 20(1). 568–568.
9.
Nie, Dekang, Yue Huang, Qianqian Liu, et al.. (2024). A Magnetic-Responsive Biomimetic Nanosystem Coated with Glioma Stem Cell Membranes Effectively Targets and Eliminates Malignant Gliomas. Biomaterials Research. 28. 123–123. 2 indexed citations
10.
Wang, Yan, et al.. (2024). Rigid-flexible nanocarriers loaded with active peptides for antioxidant and anti-inflammatory applications in skin. Colloids and Surfaces B Biointerfaces. 236. 113772–113772. 3 indexed citations
11.
Lin, Jialiang, Asma Khurshid, Richa Singhania, et al.. (2024). Cordycepin generally inhibits growth factor signal transduction in a systems pharmacology study. FEBS Letters. 599(3). 415–435. 1 indexed citations
12.
Zhao, Yongzhao, Qian Xiang, Shuai Jiang, et al.. (2023). Prevalence, diagnosis, and impact on clinical outcomes of dural ossification in the thoracic ossification of the ligamentum flavum: a systematic review. European Spine Journal. 32(4). 1245–1253. 3 indexed citations
13.
Li, Jing, Xinyue Zhang, Xiaojie Chen, et al.. (2023). Abstract A174: Antitumor activity of lipid nanoparticle-delivered anti-miR-21. Molecular Cancer Therapeutics. 22(12_Supplement). A174–A174.
14.
Lin, Jialiang, Jionghui Gu, Dongwei Fan, & Weishi Li. (2022). Herbal Formula Modified Bu-Shen-Huo-Xue Decoction Attenuates Intervertebral Disc Degeneration via Regulating Inflammation and Oxidative Stress. Evidence-based Complementary and Alternative Medicine. 2022. 1–12. 5 indexed citations
15.
Xiang, Qian, Yongzhao Zhao, Jialiang Lin, Shuai Jiang, & Weishi Li. (2022). The Nrf2 antioxidant defense system in intervertebral disc degeneration: Molecular insights. Experimental & Molecular Medicine. 54(8). 1067–1075. 107 indexed citations
16.
Wang, Longjie, Jialiang Lin, & Weishi Li. (2021). Pharmacological Mechanism of Danggui‐Sini Formula for Intervertebral Disc Degeneration: A Network Pharmacology Study. BioMed Research International. 2021(1). 5165075–5165075. 5 indexed citations
17.
Liu, Yong, Yinchuan Wang, Jialiang Lin, et al.. (2020). Alloying and brushite coating improve corrosion resistance of magnesium in a simulated physiological environment. Materials Today Communications. 26. 101750–101750. 5 indexed citations
18.
Lin, Jialiang, Jiaoxiang Chen, Zengjie Zhang, et al.. (2019). Luteoloside Inhibits IL-1β-Induced Apoptosis and Catabolism in Nucleus Pulposus Cells and Ameliorates Intervertebral Disk Degeneration. Frontiers in Pharmacology. 10. 40 indexed citations
19.
Wu, Aimin, Jason Pui Yin Cheung, Kmc Cheung, et al.. (2019). Minimum 2-Year Experience with Magnetically Controlled Growing Rods for the Treatment of Early-Onset Scoliosis: A Systematic Review. Asian Spine Journal. 13(4). 682–693. 13 indexed citations
20.
Zhang, Zengjie, Tianzhen Xu, Jiaoxiang Chen, et al.. (2018). Parkin-mediated mitophagy as a potential therapeutic target for intervertebral disc degeneration. Cell Death and Disease. 9(10). 980–980. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026